Sponge-on-a-string test to benefit NHS patients with oesophageal cancer
Eight out of ten patients who took the test were discharged without needing further testing
Read More
Tag: Oesophageal cancer
Cambridge researchers begin new trial for oesophageal cancer screening
If successful, the new test could see routine screening introduced in the NHS
Read More
MSD’s Keytruda scores EU approval in certain oesophageal cancer patients
Checkpoint inhibitor approved in combination with chemotherapy in the first-line setting for these patients
Read More
Opdivo combos show OS benefit in advanced oesophageal cancer
Opdivo plus chemotherapy or Yervoy demonstrated overall survival benefit in PD-L1-positive and all-randomised populations
Read More
EMA launches review of BMS’ Opdivo for oesophageal cancer
Company is aiming for approval in the adjuvant setting
Read More
Bristol Myers Squibb’s Opdivo shows benefit in oesophageal cancers
Data presented at 2020 ESMO virtual congress
Read More
MSD’s Keytruda shows benefit in oesophageal cancer trial
MSD’s Keytruda has shown promise in a late-stage trial testing its safety and efficacy in patients with advanced or metastatic esophageal or esophagogastric junction carcinoma.
Read More
New test could detect oesophageal cancer years earlier
Scientists have developed a new genetic test that they believe could help diagnose oesophageal cancer up to eight years before symptoms appear in people at a high risk of the disease.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
